ciprofloxacin has been researched along with Esophageal Reflux in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
" The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 7.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
" The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 3.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
"Emphysematous gastritis is a rare form of gastritis characterized by gaseous dissection of the stomach wall usually secondary to invasion by gas forming organisms, corrosive ingestion, trauma, or gastric infarction." | 1.37 | Emphysematous gastritis associated with ulcerative esophagitis. ( Abbass, K; Akram, S; Hassan, S; Markert, R, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hassan, S | 1 |
Abbass, K | 1 |
Markert, R | 1 |
Akram, S | 1 |
Al-Mobeireek, AF | 1 |
Ra, A | 1 |
Tobe, SW | 1 |
3 other studies available for ciprofloxacin and Esophageal Reflux
Article | Year |
---|---|
Emphysematous gastritis associated with ulcerative esophagitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Diabetes Mellitus, Type 2; Emphyse | 2011 |
Rapidly growing mycobacterial pulmonary infection in association with severe gastroesophageal reflux disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Gastroesophageal | 2002 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; | 2004 |